Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Vgontzas

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Archives of Internal Medicine|August 1, 1992
Predisposition to and development and persistence of chronic insomnia: importance of psychobehavioral factorsA Kales, A N Vgontzas
Annual Review of Medicine|March 12, 1999
Sleep and its disordersA N Vgontzas, A Kales
The Journal of Clinical Endocrinology and Metabolism|March 17, 2000
Interleukin-6: the endocrine cytokineD A Papanicolaou, A N Vgontzas
BMJ (Clinical Research Ed.)|May 29, 1993
Triazolam. Weight of evidence supports increased riskA Kales, E O Bixler, A N Vgontzas
BMJ (Clinical Research Ed.)|September 4, 1993
Triazolam. The evidence against is extensive and consistentA Kales, E O Bixler, A N Vgontzas
Lancet (London, England)|February 27, 1993
Adverse events after triazolam substitutionA Kales, E O Bixler, A N Vgontzas
The International Journal of Risk & Safety in Medicine|March 21, 2013
A reassessment of triazolamA Kales, A N Vgontzas, E O Bixler
Lancet (London, England)|June 19, 1993
Triazolam safetyA Kales, E O Bixler, A N Vgontzas
Pharmacology|October 1, 1995
Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamicsA N Vgontzas, A Kales, E O Bixler
Journal of Internal Medicine|June 26, 2003
Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistanceA N Vgontzas, E O Bixler, G P Chrousos
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Archives of Internal Medicine|August 1, 1992
Predisposition to and development and persistence of chronic insomnia: importance of psychobehavioral factorsA Kales, A N Vgontzas
Annual Review of Medicine|March 12, 1999
Sleep and its disordersA N Vgontzas, A Kales
The Journal of Clinical Endocrinology and Metabolism|March 17, 2000
Interleukin-6: the endocrine cytokineD A Papanicolaou, A N Vgontzas
BMJ (Clinical Research Ed.)|May 29, 1993
Triazolam. Weight of evidence supports increased riskA Kales, E O Bixler, A N Vgontzas
BMJ (Clinical Research Ed.)|September 4, 1993
Triazolam. The evidence against is extensive and consistentA Kales, E O Bixler, A N Vgontzas
Lancet (London, England)|February 27, 1993
Adverse events after triazolam substitutionA Kales, E O Bixler, A N Vgontzas
The International Journal of Risk & Safety in Medicine|March 21, 2013
A reassessment of triazolamA Kales, A N Vgontzas, E O Bixler
Lancet (London, England)|June 19, 1993
Triazolam safetyA Kales, E O Bixler, A N Vgontzas
Pharmacology|October 1, 1995
Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamicsA N Vgontzas, A Kales, E O Bixler
Journal of Internal Medicine|June 26, 2003
Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistanceA N Vgontzas, E O Bixler, G P Chrousos
Pageof 6